SMTL ID : 4zzy.1

Structure of human PARP2 catalytic domain bound to an isoindolinone inhibitor

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.20 Å

Oligo State

monomer

Ligands

1 x D7N: 2-[1-(4,4-Difluorocyclohexyl)-piperidin-4-yl]-6-fluoro-3-oxo-2,3-dihydro-1H-isoindole-4-carboxamide(Non-covalent)

D7N.1: 14 residues within 4Å: Chain A: S.108, I.111, Q.112, H.208, G.209, G.234, Y.235, Y.242, F.243, A.244, K.249, S.250, Y.253, E.338 8 PLIP interactions: 8 interactions with chain A Hydrophobic interactions: A:Y.235, A:Y.242, A:Y.242, A:Y.253, A:Y.253 Hydrogen bonds: A:G.209, A:G.209 Halogen bonds: A:S.108

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Papeo, G.M.E. et al., Discovery of 2-[1-(4,4-Difluorocyclohexyl)Piperidin-4-Yl]-6-Fluoro-3-Oxo-2,3-Dihydro-1H-Isoindole-4-Carboxamide (Nms-P118): A Potent, Orally Available and Highly Selective Parp- 1 Inhibitor for Cancer Therapy. J.Med.Chem. (2015)

Release Date

2015-08-12

Peptides

POLY [ADP-RIBOSE] POLYMERASE 2: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

POLY [ADP-RIBOSE] POLYMERASE 2

Related Entries With Identical Sequence